Related Experiment Videos
Post-transfusion purpura: a heterogeneous syndrome
Blood
|April 1, 1975
Summary
Post-transfusion purpura (PTP) may affect males and present differently than previously thought. New findings suggest PTP is a more diverse condition than initially understood.
Area of Science:
- Immunology
- Hematology
- Transfusion Medicine
Background:
- Post-transfusion purpura (PTP) is a rare condition characterized by severe thrombocytopenia following blood transfusion.
- Historically, PTP has been predominantly reported in females and associated with anti-PlA1 antibodies.
Purpose of the Study:
- To describe new cases of PTP that expand the known clinical and immunological spectrum of the disorder.
- To investigate the characteristics of antiplatelet antibodies in these novel PTP cases.
Main Methods:
- Case series describing three new patients with PTP.
- Detection of antiplatelet antibody activity using chromium-51 (51Cr) release assay and complement (C) fixation assay.
- Platelet antigen typing (PlA1) was performed on patients and normal donors.
Main Results:
- Two cases presented with atypical manifestations, broadening the definition of PTP.
- One patient was a PlA-negative male, challenging the previous observation of only female cases.
- A female patient's post-recovery platelets expressed the PlA1 antigen.
- Antiplatelet antibody activity was confirmed in all three patients via 51Cr release assay.
- One case demonstrated PTP with an antibody not specifically directed against the PlA1 antigen, identified through C fixation and 51Cr release assays.
Conclusions:
- Post-transfusion purpura may be a more heterogeneous disorder than previously recognized.
- The clinical presentation and immunological basis of PTP might be broader than current definitions suggest.
- Further research is needed to fully understand the diverse mechanisms underlying PTP.